CME Group Inc. CME
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.51B | 6.32B | 6.32B | 6.08B | 5.96B |
| Total Other Revenue | 441.70M | 433.60M | 424.50M | 422.60M | 423.00M |
| Total Revenue | 6.96B | 6.76B | 6.74B | 6.51B | 6.39B |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 6.96B | 6.76B | 6.74B | 6.51B | 6.39B |
| SG&A Expenses | 1.86B | 1.83B | 1.79B | 1.75B | 1.69B |
| Depreciation & Amortization | 333.30M | 332.50M | 331.70M | 330.90M | 331.90M |
| Other Operating Expenses | 160.20M | 157.70M | 161.10M | 166.10M | 196.50M |
| Total Operating Expenses | 2.35B | 2.32B | 2.28B | 2.25B | 2.22B |
| Operating Income | 4.61B | 4.44B | 4.46B | 4.26B | 4.16B |
| Income Before Tax | 5.77B | 5.59B | 5.60B | 5.33B | 4.85B |
| Income Tax Expenses | 1.36B | 1.31B | 1.33B | 1.26B | 1.08B |
| Earnings from Continuing Operations | 4.42K | 4.29K | 4.27K | 4.07K | 3.76K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.42B | 4.29B | 4.27B | 4.07B | 3.76B |
| EBIT | 4.61B | 4.44B | 4.46B | 4.26B | 4.16B |
| EBITDA | 4.94B | 4.77B | 4.79B | 4.59B | 4.49B |
| EPS Basic | 12.25 | 11.84 | 11.78 | 11.18 | 10.33 |
| Normalized Basic EPS | 10.01 | 9.69 | 9.70 | 9.23 | 8.41 |
| EPS Diluted | 12.19 | 11.79 | 11.72 | 11.16 | 10.32 |
| Normalized Diluted EPS | 9.97 | 9.65 | 9.66 | 9.22 | 8.40 |
| Average Basic Shares Outstanding | 1.44B | 1.44B | 1.44B | 1.44B | 1.44B |
| Average Diluted Shares Outstanding | 1.44B | 1.45B | 1.44B | 1.44B | 1.44B |
| Dividend Per Share | 5.15 | 5.10 | 5.05 | 5.00 | 4.90 |
| Payout Ratio | 81.92% | 84.16% | 95.15% | 96.58% | 103.53% |